Lisata Therapeutics, Inc. (LSTA)
3.15
-0.08
(-2.48%)
USD |
NASDAQ |
May 08, 16:00
3.17
+0.02
(+0.63%)
After-Hours: 20:00
Lisata Therapeutics EPS Diluted (Quarterly) : -0.3344 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Protalix Biotherapeutics, Inc. | -0.0684 |
| Agenus, Inc. | -0.301 |
| Curis, Inc. | 1.229 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -1.03 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.954M |
| Revenue (Quarterly) | 0.10M |
| Total Expenses (Quarterly) | 3.054M |
| Enterprise Value | 12.24M |
| Gross Profit Margin (Quarterly) | 85.00% |
| Profit Margin (Quarterly) | -2.95K% |
| Earnings Yield | -60.68% |
| Normalized Earnings Yield | -60.68 |